Clinical Trial Update: Penicillin Prophylaxis in Sickle Cell Disease (PROPS) [Phase 3]

View source ↗

Summary

The Phase 3 PROPS trial evaluating penicillin prophylaxis in sickle cell disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection
• Pneumonia
• Sickle Cell Disease

Drugs mentioned

• Penicillin (penicillin)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Anemia, Sickle Cell, Hematologic Diseases | Phase 3 | Status: COMPLETED